Skip to content

The efficacy of topical steroid (Triamcinolone Vs. Betamethasone ) for the phimosis

The efficacy of topical steroid (Triamcinolone Vs. Betamethasone ) for the phimosis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250822007
Enrollment
44
Registered
2025-08-22
Start date
2025-04-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

protect complication of phimosis , such as balanoposthitis , Urinary tract infection and urinary tract infection topical steroid, Triamcinolone, Betamethasone, phimosis

Interventions

Applied Triamcinolone cream at prepuce , two time a day . Follow up at 1 month , 2 month , 3 month . Kayaba classification for evaluated progression,Applied Betamethasone cream at prepuce , two time a
Experimental Drug,Experimental Drug
Triamcinolone,Betamethasone

Sponsors

None listed

Eligibility

Sex/Gender
Male
Age
1 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1.boy 1-15 yr 2.co -operate patient 3.Phimosis with Kayaba Classification 1, 2 ( 1.absoluted phimosis , 2.just seen urethral orifice)

Exclusion criteria

Exclusion criteria: 1.active infection 2.loss follow up

Design outcomes

Primary

MeasureTime frame
fully Response 90 day Kayaba classification grade 4,5

Secondary

MeasureTime frame
partial Response 90 day progrss of Kayaba classification but not grade 4,5

Countries

Thailand

Contacts

Public ContactARMEAN SAEMA

Pattani hospital

delzege@gmail.com073711010

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026